paclitaxel has been researched along with Angor Pectoris in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 23 (63.89) | 29.6817 |
| 2010's | 13 (36.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, JH; Doh, JH; Garg, S; Her, AY; Kim, YH; Koo, BK; Lee, JM; Nam, CW; Shin, ES | 1 |
| Inoue, K; Inoue, M; Kanaya, H; Matsubara, T; Miwa, K; Yasuda, T | 1 |
| Alfonso Manterola, F; Doncel Vecino, LJ; Fernández Díaz, JA; Fernández Portales, J; González Fernández, R; López Mínguez, JR; Martínez Cáceres, G; Martínez Romero, P; Merchán Herrera, A; Nogales Asensio, JM; Romany, S; Sandoval, J | 1 |
| Ann, SH; Her, AY; Koo, BK; Okamura, T; Shin, ES; Singh, GB | 1 |
| Li, JJ; Qin, XW; Xiang, XP; Yan, HB; Zhang, CY | 1 |
| Cinçin, A; Değertekin, M; Gemici, G; Oktay, A | 1 |
| Barlis, P; Garcia-Garcia, HM; Gonzalo, N; Ligthart, J; Onuma, Y; Regar, E; Serruys, PW | 1 |
| Daemen, J; Garcia-Garcia, HM; Kukreja, N; Onuma, Y; Serruys, PW; van Domburg, R | 1 |
| Changqi, J; Changsheng, M; Chengxiong, G; Fang, C; Fangjiong, H; Jiahui, W; Jianzeng, D; Junping, K; Qiang, L; Rong, H; Shaoping, N; Shuzheng, L; Xiaohui, L; Xin, D; Xinmin, L; Xuesi, W; Yan, Q; Yin, Z; Yujie, Z | 1 |
| Abelson, M; Brown, B; Conway, D; Hellig, F; Hirata, K; Khan, S; Kozuki, A; Miyoshi, N; Mpe, M; Ntsekhe, M; Sawada, T; Shinke, T; Shite, J | 1 |
| Batyraliev, TA; Fettser, DV; Samko, AN; Sidorenko, BA | 1 |
| Appleby, CE; Clarke, B; Curzen, N; Fath-Ordoubadi, F; Khattar, RS; Morgan, K; Neyses, L | 1 |
| Ahn, T; Han, SH; Kang, WC; Lee, K; Moon, CI; Park, YM; Shin, EK; Shin, KC; Shin, MS | 1 |
| Cannon, LA; Coe, J; Cutlip, DE; Fitzgerald, PJ; Gray, WA; Henry, TD; Hermiller, JB; Heuer, H; Mann, JT; Midei, MG; O'Shaughnessy, CD; Overlie, PA; Popma, JJ; Schwartz, LB; Stuckey, TD; Whitbourn, R; Williams, DO; Yeung, AC | 1 |
| Applegate, RJ; Cao, S; Hermiller, JB; Lansky, AJ; Nikolsky, E; Sanz, M; Sood, P; Stone, GW; Sudhir, K; Yaqub, M | 1 |
| Arnold, SV; Cohen, DJ; Kappetein, AP; Magnuson, EA; Mohr, FW; Serruys, PW; Wang, K | 1 |
| Homma, S; Ichikawa, A; Isobe, K; Kikuchi, N; Sakamoto, S; Sano, G; Satoh, K; Shibuya, K; Sugino, K; Takai, Y | 1 |
| Hariki, H; Hiranuma, N; Hirata, K; Inoue, T; Kawamori, H; Kozuki, A; Matsumoto, D; Nagoshi, R; Nakagawa, M; Nishio, R; Osue, T; Otake, H; Shinke, T; Shite, J; Taniguchi, Y | 1 |
| Ellis, SG; Kimmelstiel, C; Kosinski, E; Leon, MB; McGarry, TF; Mehran, R; Mishkel, GJ; Nikolsky, E; Russell, ME; Stone, GW | 1 |
| Bergin, P; Caputo, R; Cox, DA; Ellis, SG; Greenberg, J; Hermiller, J; Koglin, JJ; Lasala, JM; Mann, JT; O'shaughnessy, C; Popma, JJ; Stone, GW; Turco, M | 1 |
| Accapezzato, D; D'Alessandro, M; De Luca, L; Fedele, F; Mancone, M; Mariani, P; Paroli, M; Pierro, M; Porretta, A; Sardella, G | 1 |
| Hoye, A; McFadden, EP; Ruiz-Cantador, J | 1 |
| Bewig, B; Keussen, C; Lins, M; Schrader, C; von Freier, A | 1 |
| Hoye, A; Serruys, PW; Sianos, G; Vaina, S | 1 |
| Airoldi, F; Aoki, J; Carlino, M; Chieffo, A; Colombo, A; Corvaja, N; Cosgrave, J; de Feyter, PJ; Ge, L; Hoye, A; Iakovou, I; Michev, I; Montorfano, M; Ong, AT; Rodriguez Granillo, GA; Sangiorgi, GM; Serruys, PW; Sianos, G; Valgimigli, M; van der Giessen, WJ; van Domburg, RT; van Mieghem, CA | 1 |
| Ausiello, A; Contegiacomo, G; De Caterina, R; Di Iorio, C; Renda, G; Riccardi, I; Zimarino, M | 1 |
| Daemen, J; Erdman, RA; Pedersen, SS; Serruys, PW; Sonnenschein, K; van de Sande, M; van Domburg, RT | 1 |
| Aubry, P; Benamer, H; Ducrocq, G; Feldman, LJ; Himbert, D; Juliard, JM; Majdoub, MA; Sauguet, A; Steg, PG; Tchetche, D | 1 |
| Bourantas, CV; Fotiadis, DI; Katsouras, CS; Michalis, LK; Papafaklis, MI; Theodorakis, PE | 1 |
| Bartorelli, AL; Calligaris, G; De Martini, S; Fabbiocchi, F; Galli, S; Montorsi, P; Ravagnani, P; Teruzzi, G; Trabattoni, D | 1 |
| Brieger, D; Kritharides, L; Lowe, HC; Saw, W; Yamen, E | 1 |
| Chlorogiannis, I; Iliopoulos, D; Panagiotou, M; Patsa, C; Pattakos, E; Spanos, A; Stefanadi, E; Stefanadis, C; Toutouzas, K; Tsiamis, E; Vaina, S; Vavuranakis, M | 1 |
| Gawaz, M; Geisler, T; Göhring-Frischholz, K; Haase, KK; Helber, U; Herdeg, C; May, A | 1 |
| Aarøe, J; Abildgaard, U; Abildstrøm, SZ; Andersen, HR; Bligaard, N; Bøtker, HE; Engstrøm, T; Galatius, S; Galløe, AM; Hansen, PR; Jensen, JS; Junker, A; Kelbaek, H; Kristensen, SD; Krusell, LR; Lassen, JF; Madsen, JK; Rasmussen, K; Ravkilde, J; Saunamäki, K; Stephansen, GB; Thayssen, P; Thuesen, L | 1 |
| Moliterno, DJ; Mukherjee, D | 1 |
| Böhm, M; Maack, C; Maier, LS; Ritter, O | 1 |
11 trial(s) available for paclitaxel and Angor Pectoris
| Article | Year |
|---|---|
A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Treatment Outcome; Tubulin Modulators | 2014 |
Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation.
Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Artery Disease; Drug-Eluting Stents; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Time Factors; Treatment Outcome | 2009 |
STELLIUM 1: First-in-man follow-up evaluation of bioabsorbable polymer-coated paclitaxel-eluting stent.
Topics: Aged; Angina Pectoris; Coated Materials, Biocompatible; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Inflammation; Male; Middle Aged; Neointima; Paclitaxel; Polymers; Postoperative Complications; Thrombosis; Treatment Outcome | 2010 |
[Implantation of the paclitaxel-eluting stent Apollo in patients with stable angina pectoris: long-term angiographic and clinical results].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2010 |
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial.
Topics: Angina Pectoris; Cohort Studies; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Paclitaxel; Prospective Studies; Radiography; Single-Blind Method; Sirolimus; Treatment Outcome | 2012 |
Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.
Topics: Age Factors; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Laser-Assisted; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Incidence; Longitudinal Studies; Male; Myocardial Ischemia; Paclitaxel; Risk Factors; Sirolimus; Treatment Outcome | 2011 |
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Health Status; Humans; Male; Middle Aged; Paclitaxel; Patient Satisfaction; Prosthesis Design; Quality of Life; Reoperation; Retreatment; Risk Assessment; Risk Factors; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2012 |
Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).
Topics: Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Body Mass Index; Coronary Angiography; Coronary Disease; Coronary Restenosis; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Myocardial Ischemia; Obesity; Paclitaxel; Polymers; Proportional Hazards Models; Risk Factors; Stents | 2005 |
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.
Topics: Angina Pectoris; Antineoplastic Agents; Area Under Curve; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Recurrence; Stents; Treatment Outcome | 2005 |
Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Female; Humans; Immunosuppressive Agents; Interleukin-1; Interleukin-6; Male; Middle Aged; Paclitaxel; Sirolimus; Stents | 2006 |
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Thrombosis; Treatment Outcome | 2008 |
25 other study(ies) available for paclitaxel and Angor Pectoris
| Article | Year |
|---|---|
Plaque modification and stabilization after paclitaxel-coated balloon treatment for de novo coronary lesions.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Paclitaxel; Plaque, Atherosclerotic; Registries; Republic of Korea; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome | 2019 |
Comparison of sirolimus-eluting, paclitaxel-eluting, and bare-metal stents in a patient with angina pectoris: histopathological autopsy findings of the third month.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Autopsy; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Fatal Outcome; Humans; Male; Paclitaxel; Postoperative Complications; Sirolimus; Thrombosis; Treatment Outcome | 2014 |
Serial Morphological and Functional Assessment of the Paclitaxel-coated Balloon for de Novo Lesions.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome | 2016 |
Paclitaxel-induced ST-segment elevations.
Topics: Acute Coronary Syndrome; Administration, Sublingual; Angina Pectoris; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Biomarkers; Carcinoma; Coronary Angiography; Coronary Vasospasm; Creatine Kinase, MB Form; Electrocardiography; Female; Humans; Infusions, Intravenous; Middle Aged; Nitroglycerin; Ovarian Neoplasms; Paclitaxel; Stents; Treatment Outcome; Troponin T; Vasodilator Agents | 2009 |
Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/un
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Drug-Eluting Stents; Endothelium, Vascular; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Risk Factors; Sirolimus; Tomography, Optical Coherence | 2009 |
The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Percutaneous treatment with drug-eluting stent vs bypass surgery in patients suffering from chronic stable angina with multivessel disease involving significant proximal stenosis in left anterior descending artery.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cerebrovascular Disorders; Chronic Disease; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Registries; Reoperation; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; England; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Outcome | 2011 |
Predictors of edge stenosis after paclitaxel-eluting stent implantation.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Paclitaxel; Republic of Korea; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Everolimus-induced pneumonitis after drug-eluting stent implantation: a case report.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Follow-Up Studies; Humans; Male; Paclitaxel; Pneumonia; Prednisolone; Radiography, Thoracic; Retreatment; Risk Assessment; Sirolimus; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up.
Topics: Aged; Angina Pectoris; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Prolapse; Prosthesis Failure; Retrospective Studies; Sensitivity and Specificity; Sirolimus; Thrombosis; Tomography, Optical Coherence | 2013 |
Multimodality plaque ablation following failure of conventional wires and balloons to cross and to allow successful paclitaxel-eluting stent implantation of a chronic total occlusion.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Coronary Stenosis; Humans; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Stents; Treatment Failure | 2005 |
Symptoms and signs of an acute myocardial ischemia caused by chemotherapy with Paclitaxel (Taxol) in a patient with metastatic ovarian carcinoma.
Topics: Acute Disease; Angina Pectoris; Anticoagulants; Antineoplastic Agents, Phytogenic; Bradycardia; Carcinoma; Electrocardiography; Female; Follow-Up Studies; Heparin; Humans; Middle Aged; Myocardial Ischemia; Nausea; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Treatment Outcome | 2005 |
Bifurcation stenting with drug eluting stents: illustration of the crush technique.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Middle Aged; Paclitaxel; Sirolimus; Stents; Treatment Outcome | 2006 |
Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prognosis; Sirolimus; Stents; Time Factors; Treatment Outcome | 2006 |
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Collateral Circulation; Coronary Angiography; Coronary Circulation; Coronary Restenosis; Coronary Stenosis; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Stents | 2006 |
Type-D personality exerts a stable, adverse effect on vital exhaustion in PCI patients treated with paclitaxel-eluting stents.
Topics: Age Factors; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Personality Inventory; Risk Factors; Sex Factors; Stents | 2007 |
[Treatment of intrastent restenosis by drug eluting stents: experience from one cardiology centre].
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Stents; Surface Properties; Ticlopidine; Treatment Outcome | 2007 |
Coronary dilatation 10 weeks after paclitaxel-eluting stent implantation. No role of shear stress in lumen enlargement?
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Equipment Failure Analysis; Fibromuscular Dysplasia; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Middle Aged; Paclitaxel; Shear Strength; Tunica Intima; Ultrasonography, Interventional; Vasodilation | 2007 |
Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: analysis of a single center registry.
Topics: Angina Pectoris; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Thrombosis; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Incidence; Italy; Male; Paclitaxel; Prospective Studies; Sirolimus; Stents | 2007 |
Late incomplete apposition and coronary artery aneurysm formation following paclitaxel-eluting stent deployment: does size matter?
Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Aneurysm; Coronary Angiography; Drug-Eluting Stents; Female; Humans; Paclitaxel; Ultrasonography, Interventional | 2007 |
Drug eluting stents versus coronary artery bypass surgery in patients with isolated proximal lesion in left anterior descending artery suffering from chronic stable angina.
Topics: Angina Pectoris; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Chronic Disease; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Bypass; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; Time Factors; Treatment Outcome | 2007 |
Successful local antiproliferative paclitaxel delivery in a repeatedly restenosed lesion of the right coronary artery after drug eluting-stent implantation.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Catheterization; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel | 2008 |
Effectiveness of drug-eluting stents in real-world patients.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Sirolimus; Thrombosis | 2008 |
Hotline update of clinical trials and registries presented at the German Cardiac Society meeting 2008. (PEPCAD, LokalTax, INH, German ablation registry, German device registry, DES.DE registry, DHR, Reality, SWEETHEART registry, ADMA, GERSHWIN).
Topics: Ablation Techniques; Angina Pectoris; Antineoplastic Agents, Phytogenic; Cardiology; Clinical Trials as Topic; Coronary Artery Disease; Drug-Eluting Stents; Equipment Design; Germany; Heart Failure; Humans; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Registries; Societies, Medical | 2008 |